A unique case of durable complete remission after salvage with azacitidine and DLI for high risk flt-3 positive acute myeloid leukemia, following relapse 18 months post allogeneic stem cell transplant

Main Article Content

Claire Horgan
Alexandros Kanellopoulos
Shankara Paneesha
Bhuvan Kishore
Richard Lovell
Emmanouil Nikolousis *
(*) Corresponding Author:
Emmanouil Nikolousis | manos.nikolousis@heartofengland.nhs.uk


A unique case of primary refractory FLT3-itd mutated acute myeloid leukemia in an elderly patient, who achieved completed morphological remission, and FLT3-itd negativity, following 9 cycles of azacitadine in combination with escalating doses of donor lymphocyte infusions following relapse 18 months post reduced intensity HLAA mismatch Campath conditioning allogeneic stem cell transplant.

Downloads month by month


Download data is not yet available.

Article Details